DRUG vs CRD-A

Comparison between Bright Minds Biosciences Inc (DRUG, Company) and Crawford & Co. - Class A (CRD-A, Company).

DRUG is from the Healthcare sector, while CRD-A is from the Financial Services sector.

5-Year PerformanceDRUG has outperformed CRD-A, delivering a return of +21.5% compared to +7.0%

DRUG vs CRD-A - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	DRUG(COMPANY)	CRD-A(COMPANY)
Market Cap	$582M	$582M
Max Drawdown	97.68%	84.40%
Sharpe Ratio	1.38	0.39
5Y Beta	-0.80	0.82
Industry	Biotechnology	Insurance Brokers
P/E Ratio	-24.65	16.05
Forward P/E	N/A	12.58
PEG Ratio	-0.07	N/A
Dividend Yield	N/A	2.71%
5Y Dividends CAGR	N/A	4.56%
5Y EPS CAGR	8.42%	N/A
Debt to Equity	0.03%	24.68%
Free Cash Flow Yield	-2.50%	19.08%

Market Cap

DRUG

$582M

Winner

CRD-A

$582M

Max Drawdown

DRUG

97.68%

Winner

CRD-A

84.40%

Sharpe Ratio

Winner

DRUG

1.38

CRD-A

0.39

5Y Beta

Winner

DRUG

-0.80

CRD-A

0.82

Industry

DRUG

Biotechnology

CRD-A

Insurance Brokers

P/E Ratio

Winner

DRUG

-24.65

CRD-A

16.05

Forward P/E

DRUG

N/A

CRD-A

12.58

PEG Ratio

DRUG

-0.07

CRD-A

N/A

Dividend Yield

DRUG

N/A

CRD-A

2.71%

5Y Dividends CAGR

DRUG

N/A

CRD-A

4.56%

5Y EPS CAGR

DRUG

8.42%

CRD-A

N/A

Debt to Equity

Winner

DRUG

0.03%

CRD-A

24.68%

Free Cash Flow Yield

DRUG

-2.50%

Winner

CRD-A

19.08%

DRUG vs CRD-A - Historical Returns

Returns include dividend reinvestment.

Period	DRUG	CRD-A
1 month	-19.12%	+8.92%
3 months	-13.16%	+18.06%
6 months	-23.10%	-3.86%
1 year	+115.18%	+10.40%
5 years(CAGR)	+21.53%	+7.04%
10 years(CAGR)	N/A	+6.65%
Max(CAGR)	+16.70%	+2.87%

DRUG

-19.12%

Winner

CRD-A

+8.92%

DRUG

-13.16%

Winner

CRD-A

+18.06%

DRUG

-23.10%

Winner

CRD-A

-3.86%

Winner

DRUG

+115.18%

CRD-A

+10.40%

5Y(CAGR)

Winner

DRUG

+21.53%

CRD-A

+7.04%

10Y(CAGR)

DRUG

N/A

CRD-A

+6.65%

Max(CAGR)

Winner

DRUG

+16.70%

CRD-A

+2.87%

DRUG vs CRD-A - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	DRUG	CRD-A
2026	-27.32%	+1.34%
2025	+89.83%	+1.73%
2024	+1859.10%	-7.92%
2023	-63.33%	+147.47%
2022	-78.04%	-25.48%
2021	-41.30%	+8.09%
2020	N/A	-32.56%
2019	N/A	+34.22%
2018	N/A	+7.57%
2017	N/A	-6.49%
2016	N/A	+97.00%
2015	N/A	-38.28%
2014	N/A	+15.94%
2013	N/A	+36.90%
2012	N/A	+49.04%
2011	N/A	+70.23%
2010	N/A	-24.53%
2009	N/A	-56.34%
2008	N/A	+86.70%
2007	N/A	-42.62%
2006	N/A	+4.59%
2005	N/A	-10.39%
2004	N/A	+3.60%
2003	N/A	+76.03%
2002	N/A	-49.92%
2001	N/A	-9.05%
2000	N/A	-3.54%
1999	N/A	+0.09%

DRUG vs CRD-A Drawdown Comparison

The maximum drawdown for DRUG was -97.68%, occurring on Jul 11, 2024. Recovery took 740 trading sessions.

The maximum drawdown for CRD-A was -82.82%, occurring on Sep 27, 2010. Recovery took 1997 trading sessions.

The current DRUG drawdown is -36.80%. The current CRD-A drawdown is -13.34%.

Rank	DRUG	CRD-A
#1	-97.68% Nov 8, 2021 - Oct 18, 2024	-82.82% Aug 11, 2008 - Jul 18, 2016
#2	-58.28% Nov 6, 2024 - Sep 29, 2025	-70.16% Mar 18, 2002 - Aug 11, 2008
#3	-38.35% Jan 7, 2026 - Jun 15, 2026	-52.67% Dec 16, 2019 - Jun 16, 2023
#4	-27.84% Mar 22, 2021 - Aug 24, 2021	-40.76% Feb 26, 2024 - Mar 11, 2024
#5	-26.13% Oct 21, 2025 - Nov 28, 2025	-32.87% Nov 21, 2016 - Feb 1, 2019
#6	-19.30% Dec 16, 2025 - Jan 7, 2026	-30.76% Jun 29, 2001 - Mar 18, 2002
#7	-16.21% Sep 30, 2025 - Oct 9, 2025	-20.81% Mar 5, 2019 - Jun 27, 2019
#8	-14.42% Oct 11, 2021 - Nov 3, 2021	-19.53% Jun 30, 2023 - Nov 20, 2023
#9	-9.05% Oct 24, 2024 - Nov 4, 2024	-17.94% Jan 11, 2000 - Jun 20, 2001
#10	-7.65% Oct 14, 2025 - Oct 21, 2025	-12.24% Jul 18, 2016 - Nov 11, 2016
#11	-5.42% Dec 11, 2025 - Dec 16, 2025	-11.15% Dec 29, 2023 - Feb 15, 2024
#12	-4.62% Sep 24, 2021 - Sep 29, 2021	-9.95% Jul 15, 2019 - Sep 12, 2019
#13	-4.59% Dec 8, 2025 - Dec 10, 2025	-8.21% Feb 19, 2019 - Mar 1, 2019
#14	-4.38% Aug 24, 2021 - Sep 1, 2021	-5.83% Nov 2, 1999 - Dec 22, 1999
#15	-3.81% Sep 1, 2021 - Sep 17, 2021	-5.70% Sep 30, 2019 - Nov 13, 2019